VEJLE, Denmark, March 09, 2018 -- The market leading nicotine gum manufacturer, Fertin Pharma A/S, adds another milestone in the protection of compressed nicotine gum. While Fertin Pharma A/S has already obtained a large and complex patent portfolio on compressed two-layered nicotine gum, the new patent issued by the European Patent Office is believed to strengthen the competitive landscape in the segment of one-layered compressed nicotine gum. Fertin Pharma A/S has been issued numerous patents on this technology within the past decade. Now, Fertin Pharma A/S is the nicotine manufacturer with the largest patent portfolio on compressed nicotine gum.
Vice President of BD, Marketing & Sales, Anders Dam Vestergaard, announces that Fertin Pharma A/S would enforce the patent rights against any competitor infringing the patents in the field of one-layered compressed nicotine gum. This includes the newly issued patent, EP 2 229 158 B1, and other patents relevant for one-layered compressed gum technology. “It is fairly easy to detect infringement of our patent rights, and we have a close eye on our competitors in this field of technology,” says Anders Dam Vestergaard. “In addition, we believe that our complex patent portfolio makes it difficult for our competitors to even enter this technology segment without infringing our patent rights,” Anders Dam Vestergaard adds.
Further to the newly issued European patent, Fertin Pharma A/S has been issued a number of US and Indian patents with relevance in the field of one-layered compressed nicotine technology. These include US 8,603,440, US 8,722,022, US 8,524,196 and US 8,529,875.
Fertin Pharma A/S’s main premises are located in Vejle, Denmark, with additional facilities in India. Fertin Pharma A/S is considered one of the world leading developers and manufacturers of B2B nicotine chewing gum.
For further information, please contact: Anders Dam Vestergaard Tel. +45 7215 1300 www.fertin.com


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 



